Basit öğe kaydını göster

dc.contributor.authorEkmekci, Hakan
dc.contributor.authorDomaniç, Nergiz
dc.contributor.authorOzturk, ZEYNEP BANU
dc.contributor.authorUlutin, T
dc.contributor.authorBilgen, Dilek
dc.contributor.authorKökoğlu, Emine
dc.contributor.authorBayram, Çiğdem
dc.contributor.authorSoner, Ali
dc.contributor.authorSonmez, Hüseyin Avni
dc.date.accessioned2021-03-02T20:50:38Z
dc.date.available2021-03-02T20:50:38Z
dc.date.issued2005
dc.identifier.citationBilgen D., Sonmez H. A. , Ekmekci H., Ulutin T., Ozturk Z. B. , Kökoğlu E., Bayram Ç., Soner A., Domaniç N., "The relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease", CLINICAL BIOCHEMISTRY, cilt.38, sa.1, ss.92-96, 2005
dc.identifier.issn0009-9120
dc.identifier.otherav_03f52204-abb6-4f5d-911e-ac1c25464356
dc.identifier.othervv_1032021
dc.identifier.urihttp://hdl.handle.net/20.500.12627/8595
dc.identifier.urihttps://doi.org/10.1016/j.clinbiochem.2004.09.011
dc.description.abstractObjectives: The aim of the present study was to determine and correlate tissue factor pathway inhibitor (TFPI), lipoprotein (a) (Lp(a)), oxidized low-density lipoprotein (LDL) antibody (oLAB), and thiobarbituric acid reactive substances (TBARS; as a marker of lipid peroxidation) levels in patients with coronary artery disease (CAD) and in a control group.
dc.language.isoeng
dc.subjectKlinik Tıp (MED)
dc.subjectSağlık Bilimleri
dc.subjectTIBBİ LABORATUVAR TEKNOLOJİSİ
dc.subjectKlinik Tıp
dc.subjectTıp
dc.titleThe relationship of TFPI, Lp(a), and oxidized LDL antibody levels in patients with coronary artery disease
dc.typeMakale
dc.relation.journalCLINICAL BIOCHEMISTRY
dc.contributor.departmentİstanbul Üniversitesi , ,
dc.identifier.volume38
dc.identifier.issue1
dc.identifier.startpage92
dc.identifier.endpage96
dc.contributor.firstauthorID22793


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster